These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14557648)

  • 21. Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36.
    Bywaters SM; Brendle SA; Tossi KP; Biryukov J; Meyers C; Christensen ND
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29125554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes.
    Chen Y; Ghim SJ; Jenson AB; Schlegel R
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2137-46. PubMed ID: 9747722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.
    Christensen ND; Reed CA; Cladel NM; Hall K; Leiserowitz GS
    Virology; 1996 Oct; 224(2):477-86. PubMed ID: 8874508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A deletion and point mutation study of the human papillomavirus type 16 major capsid gene.
    Varsani A; Williamson AL; Jaffer MA; Rybicki EP
    Virus Res; 2006 Dec; 122(1-2):154-63. PubMed ID: 16938363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.
    Culp TD; Spatz CM; Reed CA; Christensen ND
    Virology; 2007 May; 361(2):435-46. PubMed ID: 17222883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency.
    Oumeslakht L; Ababou M; Badaoui B; Qmichou Z
    Gene; 2021 May; 782():145533. PubMed ID: 33636291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera.
    Carter JJ; Wipf GC; Madeleine MM; Schwartz SM; Koutsky LA; Galloway DA
    J Virol; 2006 May; 80(10):4664-72. PubMed ID: 16641259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.
    Seitz H; Schmitt M; Böhmer G; Kopp-Schneider A; Müller M
    Int J Cancer; 2013 Feb; 132(3):E139-48. PubMed ID: 22961598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope.
    Sadeyen JR; Tourne S; Shkreli M; Sizaret PY; Coursaget P
    Virology; 2003 Apr; 309(1):32-40. PubMed ID: 12726724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
    Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
    Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11.
    Wang X; Wang Z; Christensen ND; Dillner J
    Virology; 2003 Jun; 311(1):213-21. PubMed ID: 12832218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus type 6 virus-like particles present overlapping yet distinct conformational epitopes.
    Wang XM; Cook JC; Lee JC; Jansen KU; Christensen ND; Ludmerer SW; McClements WL
    J Gen Virol; 2003 Jun; 84(Pt 6):1493-1497. PubMed ID: 12771418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.
    Aires KA; Cianciarullo AM; Carneiro SM; Villa LL; Boccardo E; Pérez-Martinez G; Perez-Arellano I; Oliveira ML; Ho PL
    Appl Environ Microbiol; 2006 Jan; 72(1):745-52. PubMed ID: 16391114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses.
    Senger T; Becker MR; Schädlich L; Waterboer T; Gissmann L
    J Virol; 2009 Dec; 83(24):12692-701. PubMed ID: 19793806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro.
    Wei M; Wang D; Li Z; Song S; Kong X; Mo X; Yang Y; He M; Li Z; Huang B; Lin Z; Pan H; Zheng Q; Yu H; Gu Y; Zhang J; Li S; Xia N
    Emerg Microbes Infect; 2018 Sep; 7(1):160. PubMed ID: 30254257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16.
    Guan J; Bywaters SM; Brendle SA; Ashley RE; Makhov AM; Conway JF; Christensen ND; Hafenstein S
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29211035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
    Kawana K; Matsumoto K; Yoshikawa H; Taketani Y; Kawana T; Yoshiike K; Kanda T
    Virology; 1998 Jun; 245(2):353-9. PubMed ID: 9636375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope.
    Olcese VA; Chen Y; Schlegel R; Yuan H
    BMC Microbiol; 2004 Jul; 4():29. PubMed ID: 15260888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes.
    Cason J; Patel D; Naylor J; Lunney D; Shepherd PS; Best JM; McCance DJ
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2973-87. PubMed ID: 2479716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.